Search Results 2381-2390 of 18331 for rheumatoid arthritis
Patients with a suspected motility disorder, dysautonomia, rheumatic or autoimmune disease. Exclusion Criteria: Inability to comply with study procedures ...
Participation eligibility · Have a diagnosis of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer · Have ...
Rheumatology (Oxford). 2022 May 30; 61 (6):2504-2511. View PubMed; Pinto MV, Ng PS, Laughlin RS, Thapa P, Aragon Pinto C, Shelly S, Shouman K, Dyck PJ, Dyck ...
From providing the best individualized care to addressing the world's most challenging health care problems, Mayo researchers relentlessly pursue discoveries ...
Meets the 2013 American College of Rheumatology/European League Against Rheumatism classification criteria for SSc with a total score of ≥9 (Van den Hoogen et ...
Pediatric Infectious Disease Specialist. Rochester, MN. Areas of focus: Meningitis, Urinary tract infection, Osteomyelitis, Rheumatic fever, Kawasaki disease, ...
NOTE- Subjects <65 yrs of age whose only risk factor is hypertension must have a second risk factor or LV hypertrophy to qualify.Patients receiving new drug ...
... arthritis, Knee arthritis, Soft tissue sarcoma, Sarcoma, Bone metastasis, Failed total hip replacement, Failed total knee replacement, Pelvic bone tumor ...
An opioid isn't the first choice for treating chronic conditions such as arthritis, and some side effects of opioids may be particularly concerning for older ...
... factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) fusions. A Study to Evaluate DS-1062a Combined with Pembrolizumab in Advanced or ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.